After years of development, Apple’s long-rumored augmented and virtual reality headset is nearly ready. According to Bloomberg’s Mark Gurman, the company plans to announce the device sometime this spring ahead of its annual WWDC conference in June. In a sign that a launch is finally on the horizon, Apple has reportedly shared the headset with a handful of high-profile software developers, giving them a first look at its new “xrOS” software. After announcing "Reality Pro" in the spring, Gurman expects Apple to release the device in the fall.
The final sprint to get the headset out the door will impact the rest of Apple’s 2023 product lineup. On the software front, the next version of the company’s iOS operating system is likely to ship with “fewer major changes than originally planned” due to Apple reassigning software engineers to the xrOS team. “The same goes for macOS 14,” Gurman adds. Apple’s hardware plans are even less thrilling. The company has no updates of “of note” planned for its iPad, Apple Watch and audio lines. Gurman says new iPad Pro models with OLED displays are on the way, but those likely won’t arrive until 2024. He warns the upcoming Apple Silicon MacPro will be “another disappointment.” The forthcoming desktop will reportedly feature the same design as its 2019 predecessor, and you won’t be able to upgrade the computer’s RAM on your own due to the architecture of Apple’s M-series chipsets.
The only bright spots in an otherwise dull release schedule could be a new 15-inch MacBook Air and the iPhone 15. Of the latter, Gurman says the entire iPhone 15 line will feature Apple’s new Dynamic Island feature and USB-C charging. The Pro models will also include new titanium frames and haptic volume buttons.
Apple has reportedly canceled the development of a new iPhone SE. According to analyst Ming-Chi Kuo, the company recently told suppliers it would not release a fourth-generation SE model sometime in 2024. In a Medium post spotted by MacRumors, Kuo said the device would have been the debut of Apple’s first in-house 5G modem, adding that the company had planned to test and fine-tune the chip on the SE before rolling it out more broadly to the iPhone 16 and beyond. Instead, Kuo suggests Apple is now more likely to continue using Qualcomm modems through 2024.
Kuo doesn’t say why Apple shelved the fourth-generation iPhone SE or if the performance of its own 5G chip had anything to do with the decision. For the better part of a decade, Apple has tried to reduce its dependence on Qualcomm. In 2019, the two ended their bitter patent feud and signed a “multiyear” wireless chip supply deal. Months later, however, Apple bought the majority of Intel’s mobile modem business. Then, at the end of 2020, the company disclosed it was working on its own cellular chipset. There’s been little news about the project since.
Chinese billionaire Jack Ma is ceding control of Alipay owner Ant Group. Per The Wall Street Journal, the Alibaba-affiliated company announced it would end agreements that had allowed Ma to hold a dominant position within Ant Group’s corporate governance structure. The outspoken entrepreneur previously possessed more than 50 percent of voting rights at Ant, even though he did not sit on the company’s board of directors or was involved in day-to-day operations. Ma’s influenced Ant Group through a handful of investment vehicles that owned a combined 50.5 percent stake in the fintech giant.
Moving forward, Ant said Ma and nine other company executives and employees would have voting rights they had agreed to use independently of one another. Reuters estimates Ma will own 6.2 percent of Ant Group shares once the company implements the changes it announced over the weekend.
In 2020, shortly before Ant was scheduled to hold an initial public offering that was expected to raise a record $34 billion, Ma drew the ire of Chinese authorities after he called the country’s banks “state-owned pawnshops” during a speech in Shanghai. Chinese regulators went on to block the impending IPO and ordered Ant to scale down its business. Specifically, the company was ordered to return to its roots as a payment provider. A year later, authorities fined Alibaba, Ma’s other company, $2.8 billion following an antitrust investigation into alleged monopolistic practices by the company. Ma has avoided the public eye ever since.
Google has turned to India’s Supreme Court as a “last hope” to block an order that has the potential to reshape the Android ecosystem. Last October, the Competition Commission of India (CCI) fined Google $161.9 million and barred the search giant from requiring OEMs to preinstall Google apps and services on their phones. On Wednesday, an appeals tribunal rejected the company’s request to block the ruling, which is scheduled to go into effect on January 19th. According to court documents seen by Reuters, Google filed a challenge against the tribunal’s decision with the country’s top court on Saturday. The company reportedly sees the effort as its last and best hope at preventing the CCI’s order from impacting its business. Google did not immediately respond to Engadget’s comment request.
While the $161.9 million fine is tiny for Google, the order is likely to force the company to change its deals with Android manufacturers dramatically. The CCI seeks to prevent Google from including “anti-fragmentation” clauses that bar Android forks. The order would also force the company to allow third-party app stores on Google Play, and allow users to uninstall first-party apps they don’t want on their phones. India is a critical market for Google. The country is home to about 606.6 million smartphone users, and about 97 percent of the phones in India run Android. In other words, the company can’t afford to exit the market.
2022 marked the 50th anniversary of storied instrument maker Roland. But, even though we've switched over to our 2023 calendars, the company took the opportunity at CES to take one more victory lap by showing off its 50th Anniversary Concept Piano. It's an audacious electronic piano built in collaboration with Japanese furniture maker Karimoku. The outside is one piece molded from Japanese Nara oak that hides a 360-degree, 14 speaker system.
If the elegant curves stuffed to the brim with speakers aren't exciting enough for you, well I've got good news: Roland has also built speakers into drones that hover above the piano and can be controlled by the player. Unfortunately, those couldn't be flown on the show floor at CES, so Roland dangled a pair of them from wires. Those are combined with a proprietary low-latency audio connection and the company's PureAcoustic Ambience tech to create flexible natural sounding reverb that more accurately mimics what you'd hear in, say, a concert hall. And I can confirm that even in the cavernous Las Vegas Convention Center, fighting against the constant din of people and other exhibitors, the concept piano sounded amazing.
Terrence O'Brien / Engadget
Above the keyboard itself there's a large touchscreen that can be used to stream tutorials, video conference with a piano teacher, or even run Zenbeats from Roland Cloud, turning the instrument into a studio hub. There's even USB MIDI and Bluetooth connectivity for interacting with other instruments.
Of course, the Roland 50th Anniversary Concept Piano is not for sale. And never will be. This is a creation in the tradition of over-the-top concept cars. Maybe some of its features will eventually make their way to future instruments, but for now it's truly a one of a kind.
After nearly four decades in space, NASA’s retried Earth Radiation Budget Satellite (ERBS) is about to fall from the sky. On Friday, the agency said the likelihood of wreckage from ERBS harming anyone on Earth is “very low.” NASA expects most of the 5,400-pound satellite will burn upon re-entry. Earlier this week, the Defense Department predicted ERBS would re-enter the Earth’s atmosphere on Sunday at approximately 6:40PM ET, give or take 17 hours.
While it may be a household name, the Earth Radiation Budget Satellite had anything but a dull history. Per Phys.org, the Space Shuttle Challenger carried the satellite to space in 1984, a little more than a year before Challenger's heartbreaking demise in early 1986. Astronaut Sally Ride, the first American woman to fly to space, released ERBS from Challenger’s cargo hold using the spacecraft’s robotic arm. During that same mission, Ride’s crewmate, Kathryn Sullivan, became the first American woman to perform a space walk. It was also the first mission to see two female astronauts fly to space together. As for ERBS, it went on to collect ozone and atmospheric measurements until 2005. Scientists used that data to study how Earth absorbs and radiates solar energy. ERBS's contribution to science is even more impressive when you consider NASA initially expected it would only stay functional for two years.
Singaporean inventor and tech pioneer Sim Wong Hoo passed away on January 4th at the age of 67. Sim may not be a household name these days, but he founded Creative Technology (or Creative Labs in the US), the company behind the Sound Blaster brand of sound cards, back in 1981. Sound Blasters were some of the first sound cards available to consumers, and there was a time when you had to make sure your system worked with them if you wanted to listen to music and play games.
Sim established his business in the US and started selling Sound Blasters a few years later, after which Creative became the first Singaporean company to be listed on the Nasdaq exchange. The integration of sound boards into the motherboard ended Sound Blaster's popularity, but Bloomberg says the cards provided audio for more than 400 million PCs.
Under his leadership, Creative also launched a range of MP3 players, and Sim once tried to take on Apple by spending $100 million on advertising and marketing in its bid to dethrone the iPod. In 2006, Creative sued Apple for violating its patent for portable media system menus. The companies filed more lawsuits against each other after that before Apple settled with Creative and paid the company $100 million for the technology outlined in its patent.
Creative confirmed Sim's passing on its website, calling him "a visionary, inventor, and entrepreneur who gave the PC a voice." In a press release published by the company, interim CEO Song Siow Hui said in a statement:
"I have known and worked with Mr. Sim for over 30 years. This is a sad and sudden development and we feel a great loss especially since Mr. Sim and I recently had extensive discussions on the future direction of the Company. During those discussions, Mr. Sim was full of fresh vision. Even on the night before, he had a long discussion with the Engineering team and was scheduled to meet with the Online Sales team the next day. The best thing to do now is to ensure the continued smooth running of the Company, and also to execute and realise the vision and strategy that Mr. Sim had for the Company."
One swallow doesn’t make a summer, and I’m not sure if you can count four instances of a product as a trend, but it’s certainly an interesting thread at this year’s CES. At this year’s show, a quartet of companies are showing off urine analysis tools designed to be used at home by the general public. These are positioned as a natural evolution of the fitness tracker, a device you can use to keep an even closer eye on your health and fitness. Most of them are built for your toilet, testing your pee for any number of easy-to-identify maladies. But is this the next great frontier of consumer health tracking? That rather depends on the public’s desire to delve deep into their own bladders.
My cynical take: I suspect the reason we’re seeing these pop up is because the wearables world is now played out. Back in 2019, I wrote that we’d reached the point where there were no new features that could be fitted to a smartwatch, fitness tracker or ring. Or, at least, none that were as valid, effective or accurate as what you now expect every device on the market to offer. Once it was possible to put a single lead ECG in a watch, there were no new health-tracking worlds left to conquer that didn’t involve breaking the skin.
Dr. Audrey Bowden is Dorothy J. Wingfield Philips Chancellor Faculty Fellow, Associate Professor of Biomedical Engineering at Vanderbilt University, and head of the Bowden Biomedical Optics Laboratory. Dr. Bowden tells Engadget that clinical urinalysis is used as a “first line screening for many diseases and conditions such as diabetes and kidney disease,” but added that it can “also play a role in ordinary, routine checkups, such as during pregnancy.”
You may have seen your physician ask you for a urine sample and then stir a dipstick dotted with colored squares of reaction paper into the liquid you’ve just produced. In addition to visually checking urine for cloudiness (an obvious sign of a problem), these squares can run a wide variety of tests as part of this first-line screening process.
Each square corresponds to a different test, looking for factors like pH as well as the presence of blood, or white blood cells. Blood, for instance, can indicate kidney stones or cancer, while white blood cells are a clue your body is fighting an infection. If there’s excess glucose in the urine, it’s likely that diabetes is the culprit. Ketones would indicate ketosis, nitrites could indicate bacteria in the urinary tract, and so on.
Dr. Bowden added that for many conditions, urinalysis is not a “definitive diagnostic, but rather serves as an initial prompt to perform a more complete investigation.” And that since the clinical procedure has been to test for urine when there’s already evidence of a problem, it’s not clear how effective daily testing can really be.
A medical professional I interviewed, who requested anonymity for fear of compromising their professional standing, expressed skepticism both about the accuracy of these tests as well as their utility. They said that if people were running tests at home on a regular basis, it runs the risk of providing hypochondriacs with another reason to clog up care centers.
Dr. Shubha K. De (MD) is a Urologic surgeon who is presently working on a PhD in biomedical engineering. He raised a concern that, in primary care facilities, medical staff know how to validate the data they’re presented with, and to screen out false positives. This may not be the case in an at-home setting, and added that the accuracy of some tests vary wildly — a dipstick test to identify a bladder infection is roughly 80-percent accurate, but to diagnose bladder cancer, it falls to just 3 percent.
The most talked-about gadget at CES is surely Withings’ U-Scan, which even Jimmy Kimmel joked about in his opening monologue on Thursday. Given that Withings is already such a big name in the health-tracking world, it’s little surprise that it’s hogged the attention. The company showed off a device that sits on the dry part of your toilet bowl, and samples some of your trickle as you pee. Once that fluid is captured inside the device, it runs a sample through a microfluidic cartridge (with reaction paper) and uses a reader to look at the result. Once completed, the results are sent to your phone, with suggestions on what you might do to improve your health.
When it’s eventually released, U-Scan will offer a cartridge for menstrual cycle tracking, as well as one to monitor your hydration and nutrition levels. It’s this latter cartridge I tried during my time in Vegas this week, and it looked at the pH of my urine as well as the specific gravity (relative density) of my pee. But the company promises that it will eventually be able to identify nutrient levels, fat metabolism, ketones and quantities of vitamin C.
Both of these have raised red flags with professionals who are concerned that these analyses don’t suit a one-size-fits-all model. Dr. Bowden said that menstrual cycle tracking based on “‘normalization’ curves may have been developed with too narrow a demographic to capture all interested users.”
Dr. Bowden was also resistant to the idea that nutritional information can be extracted given clinical urinalysis doesn’t offer data about those markers. She said urine samples don’t really “provide reliable information over a given time window,” and added that a “daily analysis of food nutritional content may be a stretch.” Although she did say that it may be possible to detect “accumulated nutritional deficits.”
Dr. De, however, says that it may be possible to extrapolate nutritional information back to a person’s diet using urine analysis. They said that physicians currently ask patients to run 24-hour urine collections, and that fluid is then examined for specific substances — like uric acid — to make inferences on dietary intake. “This is not always perfect, and currently needs some correlation with one’s diet history,” but added that it’s plausible to imagine that, with a “user friendly app and some AI” that it could work well.
Withings is looking to develop more clinical tests, and has said that it’s already working on a way to screen for bladder cancer markers. It’s here that my source who asked not to be named feels would offer real value to groups who are at risk of the disease. They said that a targeted monitoring program may help identify instances of the cancer early, which should dramatically increase survival rates.
Daniel Cooper
Korean company Yellosis graduated from Samsung’s startup incubator some years ago, and already produces the Cym Boat personal urine testing kit. Cym Boat offers a small stick with reaction paper squares, which you then stand in a boat-shaped piece of card lined with color-calibration squares. Take a picture on your smartphone, and you’ll be able to look at the blood, protein, ketones, pH and glucose levels within your urine.
At the show, it also showed off its next-generation product, Cym Seat, which uses a metal arm to hold a paper stick under a person as they pee. Once completed, it slides the strip in front of an optical scanner, and after a minute, the results are pushed to your phone. But this device, which is expected to launch by the end of 2023 and cost around $1,000, automates the existing process rather than adding anything new.
Daniel Cooper
Similarly, Vivoo, which also offers a reaction-paper stick which can be analyzed by a smartphone app, is building its own toilet-mounted hardware, which pushes a pee stick into the toilet bowl and then pulls it back in once it’s collected a urine sample. An optical scanner then reads the reaction squares before depositing the stick in a collection bin for disposal later.
Daniel Cooper
Rounding out the group is Olive, which is taking a dramatically different tack. The device harnesses spectroscopy rather than reaction paper, with hardware that sits under your toilet seat, and a bank of LEDs flashing toward rear-mounted photodiodes. The potential for such a technology is far greater than reaction paper, and there are some studies that have pointed to being able to identify infection with it.
Olive is presently being used in a handful of locations in the Netherlands, including an assisted living facility. Co-founder Corey Katz told Engadget that one of the most surprising uses for the technology was for personnel to keep accurate records of patient bathroom visits. Katz added that work is presently under way to find a way to measure levels of protein in urine to identify instances of preeclampsia.
The company says that there’s a broad number of conditions that spectroscopy could be used to test for. This includes hydration and ketosis all the way through to stress, creatinine levels and electrolyte balances. The hope is that a finished version of the hardware will be ready to go by the end of 2023, although it’ll only be sold to business customers.
There are issues, including around data security, especially for menstrual cycle tracking in countries like the US. Companies that could expose fertility data will need to be mindful of the legal context that is presently in place post-Roe.
If Dr. De has a final concern, it’s a worry that these at-home devices will encourage patients to take medical matters into their own hands without the supervision of a physician. “If [urine analysis systems] direct you to take supplements which jeopardize pre-existing medical conditions,” for instance, “then it could be quite dangerous.”
Of course, there are other things that independent experts (and journalists) will need to test when these devices make it out into the real world. Dr. Bowden raised concerns that urinalysis tests can be “impacted by a number of external factors,” which clinical settings make an effort to control for. Will these devices be accurate enough for the jobs they’ve been bought to do? And will the conclusions they provide be worthwhile? There’s a lot to work through before these products become ubiquitous in bathrooms around the world.
Samsung may have inadvertently confirmed that it will unveil its next flagship phones early next month. According to 9to5Google, the company's Colombian website has published a page revealing that its next Galaxy Unpacked event is scheduled for February 1st, 2023. "Epic moments are approaching," it read, based on the publication's screenshot of the page, which is now no longer viewable on the website. While the announcement didn't explicitly say that the event will officially introduce the Galaxy S23, it shows the flagship series' expected triple-camera setup.
As the publication notes, the leaves and flowers in the borders of the teaser reflect the colors of the leaked renders that seemed to show Galaxy S23 and Galaxy S23 Ultra units in green and lilac. Previous reports also suggested that we'll get to see the upcoming phones in the first week of February at an Unpacked event, which is likely to take place in San Francisco. In addition, an early February Unpacked for the flagship series is consistent with previous unveilings: For the Galaxy S22 series, Samsung held an event on February 9th, 2022.
Samsung is reportedly ditching its Exynos chips and using Qualcomm's Snapdragon 8 Gen 2 SoC to power all the Galaxy S23 units sold worldwide. The Korean tech giant typically equips its Asian and European releases with Exynos chipsets, while units sold in the US come with Qualcomm processors. Other reports suggested that the Galaxy S23 will have a 200-megapixel main camera, while the base S23 and Galaxy S23 Plus models will come with a 50-megapixel main shooter. If the leaked Unpacked page is accurate, we won't have to wait long to know for sure.
There are certain things you can’t really demonstrate in the same way as other pieces of consumer electronics. A WiFi-connected urine analyzer that sits in your toilet and samples your pee for analysis is one such gadget. That’s why I had to go to a behind-closed-doors event in a private suite here at CES in Las Vegas to test out this prototype version of Withings’ U-Scan.
U-Scan is Withings first attempt at a body fluid-analysis device, albeit one with the weight of such a well-regarded brand in the health tech space. The shell-shaped hardware sits on the edge of your bowl like a scent block, and catches a small sample of fluid while you’re micturating. After around a minute, users will find conclusions about their menstrual cycle or nutrition, depending on what cartridge is installed, pushed to their phone.
Regardless of biology, you’ll need to sit down on the toilet to use this thing, and that it’s a little surprising when the hardware lights up when it starts working. You’ll certainly know when it is as well, since it makes a fairly noticeable whirring noise while your sample is processed. At this early stage, I was able to receive information about two stats: The pH of my urine as well as its specific gravity.
Now, I could reveal what my stats were, but I’d much rather not spoil the video where you can learn a little bit more about how it all works.
